Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi
Marlena S. Fejzo; Lee Anderson; Hsiao‐Wang Chen; Enrique Guandique; Ondrej Kalous; Dylan Conklin; Dennis J. Slamon
Author Information: Division of Hematology‐Oncology, Department of Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.